Project Number 1R44AG069559-01A1 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Cellular Prion Protein Targeting Monoclonal Antibody Antagonist as a Therapy for Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator SIEGERT, TIMOTHY R Principal Investigator First Name TIMOTHY Principal Investigator Last Name SIEGERT Awardee Organization ALLYX THERAPEUTICS INC. Awardee State Connecticut Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $449,995 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
